Bayer | BAYN - Market Capitalization


Bayer reported EUR39B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 92.72B 8.6B Dec/2025
Akzo Nobel EUR 10.13B 238.83M Dec/2025
Alcon AG USD 31.08B 1.97B Dec/2025
Amarin USD 290M 51M Dec/2025
Arkema EUR 3.97B 110.29M Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BASF EUR 39.65B 1.82B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Beiersdorf EUR 22.73B 3.43B Dec/2025
Corteva USD 45.29B 638M Dec/2025
Covestro EUR 12.54B 1.53B Dec/2025
Essilor EUR 125.04B 18.49B Dec/2025
Fresenius EUR 27.59B 889.91M Dec/2025
Fresenius Medical Care EUR 11.96B 1.14B Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Henkel EUR 29.28B 1.43B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Linde USD 199.1B 22.7B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Nutrien USD 29.84B 1.31B Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
PPG Industries USD 22.99B 598M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
SAP EUR 255.96B 24.02B Dec/2025
Solvay EUR 2.88B 14.82M Dec/2025
UCB EUR 46.41B 13.94B Dec/2025
Umicore EUR 4.41B 1.34B Dec/2025
Vinci EUR 69.85B 2.94B Dec/2025